Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community

Neurology

Volumn 84, Issue 2, 2015, Pages 182-189

  Devanand, D P ^a   Lee, Seonjoo ^b   Manly, Jennifer ^a   Andrews, Howard ^a   Schupf, Nicole ^a   Doty, Richard L ^c   Stern, Yaakov ^a   Zahodne, Laura B ^a   Louis, Elan D ^a   Mayeux, Richard ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL EVALUATION; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ODOR RECOGNITION TEST; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; URBAN POPULATION; VERBAL MEMORY; COGNITION DISORDERS; MILD COGNITIVE IMPAIRMENT; NEW YORK; OLFACTION DISORDERS; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NEW YORK CITY; OLFACTION DISORDERS; RISK ASSESSMENT; URBAN POPULATION;

EID: 84925958949     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.0000000000001132     Document Type: Article

References (38)

1. Hyman BT, Arriagada PV, Van Hoesen GW. Pathologic changes in the olfactory system in aging and Alzheimer's disease. Ann NY Acad Sci 1991;640:14-19.
2. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry 2007;78:30-35.
3. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987;18:597-600.
4. Tabert MH, Liu X, Doty RL, et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol 2005;58:155-160.
5. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2008;29:693-706.
6. Devanand DP, Liu X, Tabert MH, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 2008; 64:871-879.
7. Graves AB, Bowen JD, Rajaram L, et al. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status. Neurology 1999;53: 1480-1487.
8. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry 2007a;64:802-808.
9. Devanand DP, Tabert MH, Cuasay K, et al. Olfactory identification deficits and MCI in a multiethnic elderly community sample. Neurobiol Aging 2010;31:1593-1600.
10. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992;49:453-460.
11. Manly JJ, Bell-McGinty S, Tang MX, Schupf N, Stern Y, Mayeux R. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 2005;62:1739-1746.
12. Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000;55:539-544.
13. de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease: The Rotterdam Study. Arch Neurol 1997;54:762-765.
14. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science 1984;226:1441-1443.
15. Doty RL, Frye RE, Agrawal U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys 1989; 45:381-384.
16. Murphy C. Olfactory functional testing: sensitivity and specificity for Alzheimer's disease. Drug Dev Res 2002; 56:123-131.
17. Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008;63:494-506.
18. Siedlecki KL, Manly JJ, Brickman AM, Schupf N, Tang MX, Stern Y. Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology 2010;24:402-411.
19. Brickman AM, Schupf N, Manly JJ, et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008;65: 1053-1061.
20. Pepe M, Longton GM, Janes H. Estimation and comparison of receiver operating characteristic curves. Stata J 2008;9:1.
21. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-35.
22. Watfa G, Husson N, Buatois S, Laurain MC, Miget P, Benetos A. Study of Mini-Mental State Exam evolution in community-dwelling subjects aged over 60 years without dementia. J Nutr Health Aging 2011;15:901-904.
23. Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc 2008;56:1517-1521.
24. Swan GE, Carmelli D. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 2002;21:58-67.
25. Wilson RS, Arnold SE, Tang Y, Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology 2006;26:61-67.
26. Calhoun-Haney R, Murphy C. Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores. Brain Cogn 2005;58:178-182.
27. Olofsson JK, Rönnlund M, Nordin S, Nyberg L, Nilsson LG, Larsson M. Odor identification deficit as a predictor of five-year global cognitive change: Interactive effects with age and ApoE-epsilon4. Behav Genet 2009; 39:496-503.
28. Cosentino S, Scarmeas N, Helzner E, et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008;70:1842-1849.
29. Conti MZ, Vicini-Chilovi B, Riva M, et al. Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. Arch Clin Neuropsychol 2013;28:391-399.
30. Price JL, McKeel DW Jr, Buckles VD, et al. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009;30: 1026-1036.
31. Kantarci K, Senjem ML, Lowe VJ, et al. Effects of age on the glucose metabolic changes in mild cognitive impairment. AJNR Am J Neuroradiol 2010;31:1247-1253.
32. Erten-Lyons D, Dodge HH, Woltjer R, et al. Neuropathologic basis of age-associated brain atrophy. JAMA Neurol 2013;70:616-622.
33. Scheinin NM, Wikman K, Jula A, et al. Cortical 11C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging." J Alzheimers Dis 2014;41:193-202.
34. Mattsson N, Rosén E, Hansson O, et al. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 2012;78:468-476.
35. Doty RL, Kamath V. The influences of age on olfaction: A review. Front Psychol 2014;5:20. doi: 10.3389/fpsyg. 2014.0020.
36. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA 2002;288:2307-2312.
37. Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 2006;21:2062-2067.
38. Gray AJ, Staples V, Murren K, Dhariwal A, Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. Int J Geriatr Psychiatry 2001;16:513-517.